國藝集團控股(08228.HK)接獲針對公司的清盤呈請
格隆匯11月18日丨國藝集團控股(08228.HK)公佈,根據日期為2020年10月7日的債券文據,公司向債券持有人("呈請人")發行債券,本金額為50萬美元,總票息為0.1釐("債券")。
公司董事會近日獲悉,於2022年10月28日,呈請人向香港特別行政區高等法院原訟法庭提交清盤呈請,以根據香港法例第32章公司(清盤及雜項條文)條例的條文對公司進行清盤,內容有關債券的未付金額合共500,500美元(包括債券尚餘本金額共500,000美元、應計利息共500美元)。該呈請將於2023年1月4日舉行聆訊。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.